Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;41(7):1553-1562.
doi: 10.1002/nau.24989. Epub 2022 Jun 16.

Healthcare resource use and cost burden of urinary incontinence to United States payers

Manasi Datar  1 , Li-Chen Pan  1 , Jessica L McKinney  2   3 , Thomas F Goss  1 , Samantha J Pulliam  2   4
Affiliations

Healthcare resource use and cost burden of urinary incontinence to United States payers

Manasi Datar et al. Neurourol Urodyn. 2022 Sep.

Abstract

Objective: To assess healthcare resource utilization and costs for female patients diagnosed with stress or mixed urinary incontinence (SUI/MUI) compared to a matched cohort of patients without SUI/MUI.

Methods: We conducted a retrospective matched cohort study of women using the IBM MarketScan research database. Women diagnosed with SUI/MUI between July 1, 2014 and June 30, 2016 were identified using International Classification of Diseases 9 and 10 codes for SUI or MUI with the date of first diagnosis as the index date from which 2-year postindex healthcare resource use and direct cost data were derived from claims, examined, and compared 1:1 with patients without a SUI/MUI diagnosis, matched by age and Charlson's Comorbidity Index.

Results: A total of 68 636 women with SUI/MUI were matched 1:1 with controls. In the 2-year postindex date, a significantly higher proportion of SUI/MUI patients had ≥1 inpatient visit and ≥1 outpatient visit compared to the control group (inpatient: 18.89% vs. 12.10%, p < 0.0001; outpatient: 88.44% vs. 73.23%, p < 0.0001). Mean primary care visits were significantly higher in SUI/MUI patients compared to controls (7.33 vs. 5.53; p < 0.0001) as were specialist visits (1.2 vs. 0.08; p < 0.0001). Mean all-cause outpatient costs were higher in SUI/MUI patients compared to controls ($7032.10 vs. $3348.50; p < 0.0001), as were inpatient costs ($3990.70 vs. $2313.70; p < 0.0001).

Conclusion: Women with SUI/MUI consume significantly higher medical resources and incur higher costs to payers, compared to women without SUI/MUI. While reasons for this are not fully understood, improved and standardized treatment for women with SUI/MUI may positively affect cost and outcomes.

Keywords: healthcare resource utilization; mixed urinary incontinence; stress urinary incontinence; urinary incontinence; women.

PubMed Disclaimer

Conflict of interest statement

Manasi Datar, Li‐Chen Pan and Thomas Goss are employees of Boston Healthcare Associates which received consulting fees from Renovia Inc. Jessica McKinney and Samantha Pulliam are employees of Renovia Inc.

Figures

Figure 1
Figure 1
Comparison between the SUI/MUI cohort and the matched controls; Overall inpatient and outpatient visits in the postindex period, including index encounter. (A) Proportion of patients by inpatient stays; (B) Proportion of patients by outpatient visits. (A) Comparison of the proportion of inpatient visits between the Stress/Mixed Urinary Incontinence (SUI/MUI) cohort and matched controls in the postindex period. The highest proportion of patients had 0 inpatient visits in the 2‐year postindex period. The proportion of patients in the SUI/MUI cohort who had 0 inpatient visits (81.11%) was lower than those in the matched controls cohort (87.90%). (B) Comparison of the proportion of outpatient visits between the SUI/MUI cohort and matched controls in the postindex period. The highest proportion of patients had 1–5 outpatient visits in the 2‐year postindex period. The proportion of patients in the SUI/MUI cohort who had 0 outpatient visits (11.56%) was lower than those in the matched controls cohort (26.77%)
Figure 2
Figure 2
Costs of encounters (2‐year postindex, including index encounter): SUI/MUI cohort versus matched controls. All costs, outpatient costs, physician office visit costs, and inpatient costs for the SUI/MUI cohort compared to the matched controls. All categories of costs as well as total costs were higher in the SUI/MUI cohort compared to matched controls
See this image and copyright information in PMC

References

    1. Haylen BT, De Ridder D, Freeman RM, et al. An International Urogynecological Association/International Continence Society Joint Report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4‐20. 10.1007/s00192-009-0976-9 - DOI - PubMed
    1. Wu JM, Vaughan CP, Goode PS, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014;123(1):141‐148. 10.1097/AOG.0000000000000057 - DOI - PMC - PubMed
    1. Abdullah B, Ayub SH, Mohd Zahid AZ, Noorneza AR, Isa MR, Ng PY. Urinary incontinence in primigravida: the neglected pregnancy predicament. Eur J Obstet Gynecol Reprod Biol. 2016;198:110‐115. 10.1016/j.ejogrb.2016.01.006 - DOI - PubMed
    1. Fritel X, Ringa V, Quiboeuf E, Fauconnier A. Female urinary incontinence, from pregnancy to menopause: a review of epidemiological and pathophysiological findings. Acta Obstet Gynecol Scand. 2012;91(8):901‐910. 10.1111/j.1600-0412.2012.01419.x - DOI - PubMed
    1. Dieter AA, Wilkins MF, Wu JM. Epidemiological trends and future care needs for pelvic floor disorders. Curr Opin Obstet Gynecol. 2015;27(5):380‐384. 10.1097/GCO.0000000000000200 - DOI - PMC - PubMed

Publication types